Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...

Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Novartis and Relation's target discovery deal falls under Novartis’ wider ploy to strengthen its immunology portfolio.

Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...

The Harbor Health Care ETF MEDI is now three years old and has performed so well that it has been rated five stars (the highest rating) within Morningstar's U.S. Fund Health category. The ...

Dec 11 () - EU Council and Parliament negotiators reached a provisional "pharma package" deal to modernize medicine rules, speed patient access, and ​bolster competitiveness, the Council said on ...